Equity · Healthcare
Gilead Sciences, Inc. (GILD) perpetual futures
GILD perpetual futures on 7 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade GILDUSDT.
Gilead Sciences is a global biopharmaceutical company that develops and commercializes innovative therapies for HIV/AIDS, COVID-19, liver diseases, cancers, and other serious conditions.
Price chart
Use the left and right arrow keys to inspect points on the chart.
Trading data
Perpetual market activity
7/7 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
7 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
| Trade | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BingX | Trade | GILD-USDT | Trading | $146.20 | +5.5% APR +0.00500% every 8h | +19.8 bps | $2.6K | $1.2M⚠ | $1.3K | USDT | - | |
HTX | Trade | GILD/USDT | Trading | $146.36 | 0.0% APR 0.000% every 8h | +426.3 bps | $0 | $405K | $4.9K | USDT | - | |
Helix (Injective) | Trade | GILD/USDC | Trading | $146.79 | +3.6% APR +0.00042% every 1h | - | - | $85K | - | USDC | 12x | |
Bybit | Trade | GILD/USDT | Trading | $146.36 | 0.0% APR 0.000% every 8h | +13.7 bps | $2.1K | $40.8K | $64.3K | USDT | 25x | |
Bitget | Trade | GILD/USDT | Trading | $145.92 | 0.0% APR 0.000% every 8h | +18.5 bps | $470.2K | $38.1K | $80.9K | USDT | 20x | |
Gate.io | Trade | GILD/USDT | Trading | $146.61 | 0.0% APR 0.000% every 8h | +111.8 bps | $15.7K | $4.4K | $7.3K | USDT | 20x | |
LBank | Trade | GILD/USDT | Trading | $146.11 | 0.0% APR 0.000% every 8h | +13.7 bps | $488.9K | $500.1 | - | USDT | 20x |
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kThin liquidity · 2 of 7 venues absorb $10k · Typical cost: +27.1 bps – +49.2 bps
Cheapest execution: Bitget · +16.1 bps
Too thin: BingX, Bybit
No fresh book data: Gate.io, HTX, Helix (Injective)
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
GILDTightest spread
GILDHighest volume
GILDFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 4h ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 4h ago
Charts: revenue, profit, cash flow & valuation
Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
GILD-PERPFilings
PendingTranscripts
PendingLatest updates
No recent updates available.FMP company data
Company intelligence
Updated: Sep 15, 2026, 03:25 AM UTC
FMP company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Daniel O'Day
- Employees
- 17,000
- IPO date
- Jan 22, 1992
- Country
- US
- Exchange
- NASDAQ Global Select
Rating factors
- Return on equityi
- 1
- Return on assetsi
- 1
- Debt to equityi
- 1
- Price to earningsi
- 1
- Price to booki
- 1
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.22% | 39.5M |
| VOO | 0.25% | 32.6M |
| QQQ | 0.8% | 26.4M |
| IVV | 0.27% | 15.9M |
| 1657.T | 0.21% | 15.9M |
| SPY | 0.27% | 15.2M |
| FXAIX | 0.25% | 14.4M |
| VTV | 0.6% | 11.8M |
| VCPA.S | 0.23% | 11M |
| XLV | 3.01% | 9M |
| FCNKX | 0.67% | 8M |
| VIG | 0.7% | 7M |
Analyst track record
How the analysts covering GILD have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 220 | 664 |
| Analysts | 29 | 44 |
| Buy / hold / sell | 185 / 35 / 0 | 475 / 189 / 0 |
| Upgrades / downgrades / initiations | 3 / 1 / 3 | 13 / 3 / 9 |
| Price targets hit / missed | 78 / 119 (40%) | 475 / 119 (80%) |
| Avg. return after a rating (TipRanks) | -1.1% | +56.4% |
| Best / worst call | +52.4% / -19.6% | +14,381.0% / -19.6% |
After buy calls on this stock: median 21-day move +1.1% vs S&P 500 -0.5% (n = 475)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Evan SeigermanBMO Capital100% hit rate on this stock · 26 targets measuredBuytarget $174Aug 27, 2026
- Tyler Van BurenTD Cowen100% hit rate on this stock · 23 targets measuredBuytarget $160Aug 4, 2026
- Terence FlynnMorgan Stanley100% hit rate on this stock · 17 targets measuredBuytarget $165Aug 20, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 10, 2026 | Morten HerholdtHSBC | BuyMaintained | $175 | article ↗ |
| Sep 7, 2026 | Courtney BreenBernstein | BuyMaintained | $160 | article ↗ |
| Aug 31, 2026 | Salim SyedMizuho Securities | BuyMaintained | $170 | article ↗ |
| Aug 28, 2026 | Gregory RenzaTruist Financial | BuyMaintained | – | article ↗ |
| Aug 27, 2026 | Evan SeigermanBMO Capital | BuyMaintained | $174 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Sep 11, 2026 · 220 ratings
Frequently asked questions
Where can I trade GILD perpetual futures?
Gilead Sciences, Inc. (GILD) perpetual futures trade on 7 crypto venues, including BingX, HTX, Helix (Injective). PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade GILD around the clock?
Yes. Unlike the underlying stock, GILD perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on GILD perpetuals?
Right now the GILD perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to +5.5% across 7 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the GILD perp price compare to the Gilead Sciences, Inc. stock?
The venue-median GILD perp mark is $146.4 versus a reference stock price of $146.1, a basis of +0.2%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a GILD perpetual future?
A GILD perpetual is a derivative that tracks the price of Gilead Sciences, Inc. with no expiry date. It lets you take long or short exposure to Gilead Sciences, Inc. on crypto venues, around the clock.
What is GILDUSDT perpetual?
GILDUSDT is the symbol most crypto exchanges use for the Gilead Sciences, Inc. perpetual settled in USDT (Tether). It tracks the GILD share price through an index, trades 24/7 with leverage and never expires.
BingX
HTX
Helix (Injective)
Bybit
Bitget
Gate.io
LBank